Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
32,315,113
-
Total 13F shares
-
4,019,753
-
Share change
-
-172,954
-
Total reported value
-
$34,733,851
-
Price per share
-
$8.64
-
Number of holders
-
58
-
Value change
-
-$1,812,345
-
Number of buys
-
22
-
Number of sells
-
27
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2022
As of 31 Mar 2022,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,019,753 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, NORTHERN TRUST CORP, Nuveen Asset Management, LLC, Allspring Global Investments Holdings, LLC, and Bank of New York Mellon Corp.
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.